Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V. Chin KM, et al. Among authors: kim nh. Am Heart J. 2014 Feb;167(2):218-225.e1. doi: 10.1016/j.ahj.2013.08.008. Epub 2013 Oct 16. Am Heart J. 2014. PMID: 24439983 Free article. Clinical Trial.
Chronic thromboembolic pulmonary hypertension.
Williamson TL, Kim NH, Rubin LJ. Williamson TL, et al. Among authors: kim nh. Prog Cardiovasc Dis. 2002 Nov-Dec;45(3):203-12. doi: 10.1053/pcad.2002.130159. Prog Cardiovasc Dis. 2002. PMID: 12525996 Review.
Interventional and surgical modalities of treatment in pulmonary hypertension.
Keogh AM, Mayer E, Benza RL, Corris P, Dartevelle PG, Frost AE, Kim NH, Lang IM, Pepke-Zaba J, Sandoval J. Keogh AM, et al. Among authors: kim nh. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S67-S77. doi: 10.1016/j.jacc.2009.04.016. J Am Coll Cardiol. 2009. PMID: 19555860 Free article. Review.
End points and clinical trial design in pulmonary arterial hypertension.
McLaughlin VV, Badesch DB, Delcroix M, Fleming TR, Gaine SP, Galiè N, Gibbs JSR, Kim NH, Oudiz RJ, Peacock A, Provencher S, Sitbon O, Tapson VF, Seeger W. McLaughlin VV, et al. Among authors: kim nh. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S97-S107. doi: 10.1016/j.jacc.2009.04.007. J Am Coll Cardiol. 2009. PMID: 19555863 Free article. Review.
Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel.
Sista AK, Goldhaber SZ, Vedantham S, Kline JA, Kuo WT, Kahn SR, Kabrhel C, McLaughlin VV, White SB, Kim NH, Gray M, Simon MA, Benenati JF, Misra S, Sterling KM, Kee ST, Konstantinides SV, Jaff MR, Kearon C. Sista AK, et al. Among authors: kim nh. J Vasc Interv Radiol. 2016 Jun;27(6):787-94. doi: 10.1016/j.jvir.2016.03.035. Epub 2016 Jun 3. J Vasc Interv Radiol. 2016. PMID: 27287967 No abstract available.
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
Frost A, Janmohamed M, Fritz JS, McConnell JW, Poch D, Fortin TA, Miller CE, Chin KM, Fisher M, Eggert M, McEvoy C, Benza RL, Farber HW, Kim NH, Pfister T, Shiraga Y, McLaughlin V. Frost A, et al. Among authors: kim nh. J Heart Lung Transplant. 2019 Jan;38(1):43-50. doi: 10.1016/j.healun.2018.09.003. Epub 2018 Sep 12. J Heart Lung Transplant. 2019. PMID: 30391194 Free article. Clinical Trial.
2,366 results